partners

Partnering with IMI

Presented below are points to note when considering a future partnership with IMI.
Please consider these points and, if you are interested, please contact us.

Key points for overseas manufacturers when considering partnering with IMI

01Is the Japanese healthcare system and medical device market attractive to manufacturers?

02Is it difficult to enter the medical device market in Japan?

03IMI's platform for partners

04Which categories do your latest high-tech therapeutic devices fall into?

Are the Japanese medical system and medical device market attractive to manufacturers?

  1. In terms of medical costs, Japan ranked 12st among OECD countries with a total medical cost in GDP of 9.6% and 18st with a per-capita medical cost of $3,213.
  2. In terms of market size for medical devices, the U.S. ranked first at 11 trillion yen, Germany second at 2.7 trillion yen and Japan third at 2.6 trillion yen.
  3. The Japanese government designated the healthcare industry as a strategic growth industry in 2010 and plans to develop it into a 30 trillion yen market by 2020. It is also considering a medical tourism plan.

Is it difficult to enter the medical device market in Japan?

The following characteristics of the medical device market in Japan have been reported by the U.S. Department of Commerce.

Seriously, Japan is a tough market

  1. Cost contamination pressure
  2. Over regulation
  3. High cost of doing business
  4. Protectionism
  5. Unique and complex market culture
  6. Competitive Japanese firms

( U.S. Commercial Service)

IMI's platform for partners

Our service platform is useful not only to medical institutions but also our partner device manufacturers.
By using the platform, manufacturers can access five support services that provide necessary functions such as applications under the Pharmaceutical Affairs Law, safety management, marketing, distribution of products, etc.
that enable prompt profitability. Furthermore, partners can obtain feedback from the market and customers.

Why do medical institutions select our service platform?

Medical institutions select our service platform because it provides products and services that lead to solutions to their problems in a way that creates added value for them.

Which categories do your latest high-tech therapeutic devices fall into?

The products we deal with and the medical fields of our activities are shown in the following diagram.
Where will your products be used?
(NOTE)
*IMI may consider partnerships with manufacturers in categories other than those listed below.

Main products used in different hospital departments

Products used in different clinical settings

(IMI survey data, December of 2010)

btn_contactus

If you are interested in creating a partnership with IMI,
please contact us.

We are looking forward to hearing from you.

Back to top